Citations

Clear

162 citation(s) found for "Jevremovic, Dragan".

The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment
Muchtar, Eli , Jevremović, Dragan , Dispenzieri, Angela , Dingli, David , Lacy, Martha Q. , Hayman, Suzanne R. , Kapoor, Prashant , Russell, Stephen J. , Lust, John A., Lin, Yi , Chakraborty, Rajshekhar , Zeldenrust, Steven R., Kumar, Shaji , Kyle, Robert A. , Gertz, Morie A , Buadi, Francis K. , Gonsalves, Wilson I. , Leung, Nelson , Go, Ronald S. , Rajkumar, S. Vincent , Gertz, Morie A. , Muchtar, E , Dispenzieri, Angela , Russell, Stephen J , Jevremovic, Dragan , Chakraborty, Rajshekhar , Dingli, David , Lin, Yi

Mayo Clinic

Blood | October 12, 2016 | Volume: 129 | Issue: 1 | Pages: 82-87

10.1182/blood-2016-06-721878 | PMID 27729322 Get It

Key PointsThe monotypic and polytypic PC compartments assessed by MFC are prognostic in AL amyloidosis. MFC may play a role in the definition of hematologic response to treatment.
Disseminated Mycobacterium chimaera Infection After Cardiothoracic Surgery
Tan, Nicholas Y. , Sampath, Rahul , Saleh, Omar Abu , Jevremović, Dragan , Alniemi, Saba T. , Wengenack, Nancy L. , Sampathkumar, Priya , Badley, Andrew D. , Tweet, Marysia S. , Jevremovic, Dragan , Badley, Andrew D

Mayo Clinic

Open Forum Infectious Diseases | June 17, 2016 | Volume: 3 | Issue: 3 | Pages: No page available

10.1093/ofid/ofw131 | PMID 27703994 Get It

Abstract Ten case reports of disseminated Mycobacterium chimaera infections associated with cardiovascular surgery were published from Europe. We report 3 cases of disseminated M chimaera infections with histories of aortic graft and/or valvular surgery within the United States. Two of 3 patients demonstrated ocular involvement, a potentially important clinical finding.
Decreased normal NK-cells is a characteristic of T-cell large granular lymphocytic leukemia and is strongly associated with cytopenia
Neff, Jadee , Jevremović, Dragan , Morice, William G. , Neff, Jadee L, Shi, Min , Morice, William George , Jevremovic, Dragan

Mayo Clinic

Leukemia & Lymphoma | December 21, 2015 | Volume: 57 | Issue: 5 | Pages: 1230-1233

10.3109/10428194.2015.1081191 | PMID 26689813 Get It

Loss of Blast Heterogeneity in Myelodysplastic Syndrome and Other Chronic Myeloid Neoplasms
Jevremović, Dragan , Timm, Michael, Reichard, Kaaren K. , Morice, William G. , Hanson, Curtis A. , Viswanatha, David S., Howard, Matthew T., Nguyen, Phuong L., Timm, Michael M, Morice, William George , Jevremovic, Dragan

Mayo Clinic

American Journal of Clinical Pathology | August 14, 2014 | Volume: 142 | Issue: 3 | Pages: 292-298

10.1309/ajcp73qsllydegxk | PMID 25125617 Get It

Abstract Objectives: Flow cytometry immunophenotyping has been suggested as an adjunctive technique in the evaluation of myeloid malignancies, especially in the myelodysplastic syndromes. However, its use has been limited due to complexity and cost restraints. The goal of this study is to attempt a simpler approach to flow cytometry immunophenotyping in myeloid neoplasms. Methods: We analyzed bone marrow specimens of 45 selected patients and an additional 99 consecutive random patients using a limited antibody panel. Results: Normal CD34-positive blasts show a characteristic pattern of CD13/HLA-DR expression, with three readily identifiable subpopulations. In contrast, myeloid neoplasms frequently show loss of this heterogeneity. Conclusions: Analysis of a limited antibody panel with a focus on CD13/HLA-DR expression provides relatively high specificity and sensitivity for the detection of myeloid neoplasms.
Gene Therapy to Manipulate Effector T Cell Trafficking to Tumors for Immunotherapy
Gough, Michael J. , Crittenden, Marka R. , Thanarajasingam, Uma , Sánchez-Pérez, Luis, Thompson, Jill , Jevremović, Dragan , Vile, Richard G. , Gough, Michael, Jevremovic, Dragan

Mayo Clinic

The Journal of Immunology | April 22, 2014 | Volume: 174 | Issue: 9 | Pages: 5766-5773

10.4049/jimmunol.174.9.5766 | PMID 15843579 Get It

Abstract Strategies that generate tumor Ag-specific effector cells do not necessarily cure established tumors. We hypothesized that the relative efficiency with which tumor-specific effector cells reach the tumor is critical for therapy. We demonstrate in this study that activated T cells respond to the chemokine CCL3, both in vitro and in vivo, and we further demonstrate that expression of CCL3 within tumors increases the effector T cell infiltrate in those tumors. Importantly, we show that adenoviral gene transfer to cause expression of CCL3 within B16ova tumors in vivo increases the efficacy of adoptive transfer of tumor-specific effector OT1 T cells. We additionally demonstrate that such therapies result in endogenous immune responses to tumor Ags that are capable of protecting animals against subsequent tumor challenge. Strategies that modify the “visibility” of tumors have the potential to significantly enhance the efficacy of both vaccine and adoptive transfer therapies currently in development.
Regulation of NK Cell-Mediated Cytotoxicity by the Adaptor Protein 3BP2
Jevremović, Dragan , Billadeau, Daniel D. , Schoon, Renee A., Dick, Christopher J., Leibson, Paul J., Jevremovic, Dragan

Mayo Clinic

The Journal of Immunology | April 20, 2014 | Volume: 166 | Issue: 12 | Pages: 7219-7228

10.4049/jimmunol.166.12.7219 | PMID 11390470 Get It

Abstract Stimulation of lymphocytes through multichain immune recognition receptors activates multiple signaling pathways. Adaptor proteins play an important role in integrating these pathways by their ability to simultaneously bind multiple signaling components. Recently, the 3BP2 adaptor protein has been shown to positively regulate the transcriptional activity of T cells. However, the mechanisms by which signaling components are involved in this regulation remain unclear, as does a potential role for 3BP2 in the regulation of other cellular functions. Here we describe a positive regulatory role for 3BP2 in NK cell-mediated cytotoxicity. We also identify p95vav and phospholipase C-γ isoforms as binding partners of 3BP2. Our results show that tyrosine-183 of 3BP2 is specifically involved in this interaction and that this residue critically influences 3BP2-dependent function. Therefore, 3BP2 regulates NK cell-mediated cytotoxicity by mobilizing key downstream signaling effectors.
Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria
Jevremović, Dragan , Béné, Marie C. , Yan, Ming , Jacobs, Patrick L., Litwin, Virginia , Group, ; on behalf of ICSH/ICCS Working, Wood, Brent L. , Group, ; on behalf of ICSH/ICCS Working, Jevremovic, Dragan

Mayo Clinic

Cytometry Part B: Clinical Cytometry | September 11, 2013 | Volume: 84 | Issue: 5 | Pages: 315-323

10.1002/cyto.b.21108 | PMID 24022854 Get It

Multi‐color flow cytometry is a unique technology, which enables the analysis of heterogeneous cellular systems and provides multiparametric information on a cell‐by‐cell basis. A variety of factors contribute to the complexity of validating cell‐based flow cytometric methods, including the lack of fully characterized cellular reference materials and the difficulty in obtaining, or creating, samples with varying levels of a given cell type or varying levels of expression of a given antigen. This document summarizes validation requirements and describes validation strategies for quasi‐quantitative and qualitative cell‐based flow cytometric assays. © 2013 International Clinical Cytometry Society
Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
Galivo, Feorillo , Díaz, Rosa María, Thanarajasingam, Uma , Jevremović, Dragan , Wongthida, Phonphimon , Thompson, Jill , Kottke, Timothy, Barber, Glen N. , Vile, Richard G. , Melcher, Alan , Jevremovic, Dragan

Mayo Clinic

Human Gene Therapy | November 18, 2009 | Volume: 21 | Issue: 4 | Pages: 439-450

10.1089/hum.2009.143 | PMID 19922169 Get It

Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood
Gulati, Rajiv , Jevremović, Dragan , Peterson, Timothy E., Chatterjee, Suvro , Shah, Vijay H. , Vile, Richard G. , Simari, Robert D., Jevremovic, Dragan

Mayo Clinic

Circulation Research | November 11, 2003 | Volume: 93 | Issue: 11 | Pages: 1023-1025

10.1161/01.res.0000105569.77539.21 | PMID 14605020 Get It

Cells with endothelial phenotype generated from adult peripheral blood have emerging diagnostic and therapeutic potential. This study examined the lineage relationship between, and angiogenic function of, early endothelial progenitor cells (EPCs) and late outgrowth endothelial cells (OECs) in culture. Culture conditions were established to support the generation of both EPCs and OECs from the same starting population of peripheral blood mononuclear cells (PBMCs). Utilizing differences in expression of the surface endotoxin receptor CD14, it was determined that the vast majority of EPCs arose from a CD14 + subpopulation of PBMCs but OECs developed exclusively from the CD14 − fraction. Human OECs, but not EPCs, expressed key regulatory proteins endothelial nitric oxide synthase (eNOS) and caveolin-1. Moreover, OECs exhibited a markedly greater capacity for capillary morphogenesis in in vitro and in vivo matrigel models, tube formation by OECs being in part dependent on eNOS function. Collectively, these data indicate lineage and functional heterogeneity in the population of circulating cells capable of assuming an endothelial phenotype and provide rationale for the investigation of new cell-therapeutic approaches to ischemic cardiovascular disease.